Skip to content

Press Releases


Filter Releases
 
Press Releases
Date Title and Summary View
Feb 21, 2018
PLAINSBORO, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART),...
Feb 1, 2018
PLAINSBORO, N.J., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a ...
Jan 8, 2018
Preliminary Fourth Quarter Highlights: Fourth quarter 2017 reported revenue is expected to be approximately $365 million, exceeding the high-end of the company's previous implied guidance range of $345 million to $355 million;Organic revenue growth in the fourth quarter is expected to be abo...
Dec 21, 2017
PLAINSBORO, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading globa...
Dec 11, 2017
PLAINSBORO, N.J., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a le...
Oct 26, 2017
Revenue Increased 11.4% to $279 million; Organic Revenue Increased 1.5%  Reported EPS of $0.04; Adjusted EPS of $0.45 PLAINSBORO, N.J., Oct. 26, 2017 (GLOBE NEWSWIRE) -- ...
Oct 11, 2017
PLAINSBORO, N.J., Oct. 11, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a...
Oct 6, 2017
PLAINSBORO, N.J., Oct. 06, 2017 (GLOBE NEWSWIRE) -- ...
Oct 3, 2017
PLAINSBORO, N.J., Oct. 03, 2017 (GLOBE NEWSWIRE) -- ...
Oct 3, 2017
PLAINSBORO, N.J., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the expansion of its acellular dermal tissue matrix (ADM) product line for plastic and reconstructive surgery, including breast reconstruction in Europe, with the introduction of Integra® SurgiMend&...
Oct 2, 2017
PLAINSBORO, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a gl...
Sep 26, 2017
PLAINSBORO, N.J., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), ...
Sep 21, 2017
PLAINSBORO, N.J., Sept. 21, 2017 (GLOBE NEWSWIRE) -- ...
Sep 11, 2017
Natus Medical to acquire global Camino® ICP monitoring product line, U.S. rights to Integra's fixed pressure shunts, and U.S. rights to Codman's DURAFORM®, EVD catheters and CSF collection systems Integra is providing a preliminary estimate for a fourth quarter 2017 revenue contribut...
Aug 17, 2017
PLAINSBORO, N.J., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a le...
Page:
...
Next Last
 
= add release to Briefcase